Estamos no ar no ! Saiba mais
162,99 USD
-4,24
2,54%
No fechamento Atualizado 16 de out. 16:00 EDT
Pré-mercado
Após o fechamento do mercado
162,99
0,00
0%
1 dia
-2,54%
5 dias
2,04%
1 mês
4,74%
3 meses
0,51%
6 meses
29,32%
No acumulado do ano
17,66%
1 ano
39,92%
5 anos
-27,69%
10 anos
11,72%
 

Sobre: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Funcionários: 13.000

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 40%
Neutro 60%
Negativo 0%
Positivo
Zacks Investment Research
há 7 dias
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Neutro
Seeking Alpha
mês passado
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Neutro
GlobeNewsWire
mês passado
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
ICU Medical to Participate in Upcoming Investor Conferences
Positivo
Benzinga
há 2 meses
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
Neutro
Seeking Alpha
há 2 meses
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
Positivo
MarketBeat
há 2 meses
ICU Medical Q2 Earnings Call Highlights
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
ICU Medical Q2 Earnings Call Highlights
Neutro
Zacks Investment Research
há 2 meses
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
Positivo
Zacks Investment Research
há 2 meses
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
Neutro
GlobeNewsWire
há 2 meses
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
Neutro
GlobeNewsWire
há 2 meses
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
Gráficos de preços implementados com Lightweight Charts™